- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01288248
Noninferiority Clinical Trial With Laryngeal Mask and Endotracheal Tube
The Risk of Laryngospasm in Children is Similar to the Use of the Laryngeal Mask and the Endotracheal Tube in Children 2 Years to 14 Years: Clinical Trial Randomized Noninferiority
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Laryngospasm, defined as closure of the glottis as a protective reflex secondary to abnormal stimulation (7), with a reported incidence in the general population of 8.7 per 1000 patients undergoing surgical procedures (8), is considered the most common event among the complications in the management of pediatric airway, causing 40% of obstructive events after extubation (7-8), with incidents reported in the American pediatric population from 0.4% to 14% (8-9) for population under 6 years and 3.6% in > 6 years. Among the risk factors associated with the development of laryngospasm and anesthesia in children are: age, ASA (4), upper respiratory infection (10), among others, however in recent years has gained interest and generated dispute the association between this outcome and the type of device used to secure the airway during anesthesia. Although the endotracheal tube device is considered the "gold standard" for airway management, this has been associated with an increased incidence of laryngospasm (8), explained this phenomenon, apparently by direct stimulation because the tube into the larynx and trachea, which triggers, in theory, a posterior laryngeal reflex intense (11).
In recent years, with the advent of new devices for securing the airway, especially supraglottic use type Classic Laryngeal Mask (LM), it was thought that the main trigger of laryngospasm, laryngeal and tracheal stimulation caused by the endotracheal tube (ETT), would be resolved and will decrease the incidence of complications in the pediatric population; however, three recent prospective studies (10-11-12) is no statistically significant difference in incidence of laryngospasm among laryngeal mask and endotracheal tube. By contrast, two retrospective studies (6.4) have shown increased incidence of laryngospasm compared to ETT in children. In 2002, one of the aforementioned prospective studies (11), found an incidence of laryngospasm 11.2% versus 16.9% for ETT versus ML, respectively, but without an increase in relative risk statistically significant when comparing the ML to ETT.
In view of these findings and considering that most studies in this respect seem to have technical and methodological limitations, our objective is to determine by controlled clinical trial non inferiority the risk of laryngospasm with the endotracheal tube vs a device supraglottic, Classic Laryngeal Mask type as a method of airway patency in the pediatric population, assuming that the risk of laryngospasm with both devices is equal.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Antioquia
-
Medellin, Antioquia, Colombia, 05001000
- Hospital Foundation St. Vincent de Paul
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ASA I and III children, 1-14 years of age
- Children scheduled for surgery or therapeutic procedures under general anesthesia and fasting as defined in the fasting guidelines
- Responsible adult patients whose accept and sign the informed consent of study
Exclusion Criteria:
- Surgery of the head, neck, chest and/or abdomen (except the abdominal wall)
- Position different than the supine in surgery
- Malformations or anatomic abnormalities of the face and airway
- Procedures over 3 hours
- Patients with pulmonary aspiration risk: morbid obesity, intestinal obstruction, gastrointestinal bleeding, gastroparesis, gastroesophageal reflux
- Patients with limited mouth opening or cervical spine extension and classified as difficult airway
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Airway laryngeal mask classic
Ventilation with Airway laryngeal mask classic during surgery
|
This group includes patients with the randomization process are assigned to use Classic laryngeal mask as a method to secure the airway after induction of anesthesia, which will be maintained during surgery and removed the patient asleep once you are done the surgical procedure to determine the presence or absence of laryngospasm. The laryngeal mask mark to be used will laryngeal Mask Device ® which comes in different sizes and sterilized in ethylene oxide. The size of the Classic laryngeal mask is used according to the weight assigned
Other Names:
|
Active Comparator: endotracheal tube
Ventilation with endotracheal tube during surgery
|
This group includes patients with the randomization process are allocated to use endotracheal tube method for securing the airway after induction of anesthesia, which will be maintained during surgery and removed in the awake patient when you finish the surgical procedure to determine the presence or absence of laryngospasm. The marks of the endotracheal tube will be one of the following: Kendall Curity ®, Well Lead Medical ®, Meditec ®, which are not reusable. The size of the endotracheal tube be allocated according to age.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Laryngospasm clinically manifested as inspiratory stridor and/or expiratory, no breath sounds, paradoxical movement of the thorax and abdomen and desaturation, bradycardia, central cyanosis.
Time Frame: The appearance of the outcome will be measured from anesthetic induction until the patient is fully awake
|
It should be noted that once the subject of study presents the primary outcome may end up changing the device to improve ventilation.
|
The appearance of the outcome will be measured from anesthetic induction until the patient is fully awake
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Desaturation defined as SaO2 < 90% in pulse oximetry associated with laryngospasm
Time Frame: from anesthetic induction until the patient is fully awake
|
from anesthetic induction until the patient is fully awake
|
Presence of bradycardia in the cardioscope as reported for the age.
Time Frame: from anesthetic induction until the patient is fully awake
|
from anesthetic induction until the patient is fully awake
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Olga Lucia Giraldo Salazar, MD, MsH, Foundation Hospital San Vicente de Paul, St. Vincent Foundation
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Anestudea-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bradycardia
-
Augusta UniversityCompletedFetal BradycardiaUnited States
-
University of Maryland, BaltimoreCompleted
-
Chun Chieh WangEnrolling by invitation
-
University of Sao Paulo General HospitalCompletedFetal Bradycardia | Hypertonic Uterine | CatecholaminesBrazil
-
University of ExeterRoyal Devon and Exeter NHS Foundation TrustCompletedSVT | Vagal BradycardiaUnited Kingdom
-
Medical University of GdanskCompletedBradycardia During Pulling of EyeballPoland
-
Abbott Medical DevicesCompletedStandard Bradycardia Pacing IndicationFrance, Germany, Italy, Japan
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
-
South Western Ambulance Service NHS Foundation...Royal Devon and Exeter NHS Foundation Trust; Academic Health Science CentresCompletedEmergencies | SVT | Vagal BradycardiaUnited Kingdom
-
Unyime ItukRecruitingFetal Heart Rate or Rhythm Abnormality Affecting Fetus | Fetal Bradycardia Complicating Labor and Delivery | Fetal Bradycardia During LaborUnited States
Clinical Trials on Airway laryngeal mask classic
-
Marmara UniversityCompleted
-
Korea University Anam HospitalCompletedAnesthesiaKorea, Republic of
-
Zonguldak Bulent Ecevit UniversityCompletedVentilation | Airway Management | EducationTurkey
-
Milton S. Hershey Medical CenterCompletedAdverse Effect of Unspecified General AnestheticsUnited States
-
Eye & ENT Hospital of Fudan UniversityNot yet recruitingAnesthesia Intubation Complication
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedChildrenUnited States
-
XiQiang HuangSun Yat-sen UniversityUnknownBody Weight | Complication | Size of Laryngeal Mask Airway | Success Rate of First Attempt
-
Rabin Medical CenterCompletedChronic Obstructive Pulmonary Disease | Respiratory Disease Undergoing Elective Bronchoscopy.Israel
-
Baskent UniversityCompletedAdenoidectomy Surgery | Flexible-Laryngeal Mask Airway
-
Asan Medical CenterCompletedUrinary Bladder Neoplasms | Laryngeal MasksKorea, Republic of